Franz Obermayr
Directeur Général chez Panoptes Pharma GmbH
Provenance du réseau au premier degré de Franz Obermayr
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 11 | |
Panoptes Pharma GmbH
 Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria.
1
| Subsidiary | Biotechnology | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Franz Obermayr via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Masters Business Admin Undergraduate Degree | |
| VAXART, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Ora, Inc.
 Ora, Inc. Medical/Nursing ServicesHealth Services Ora, Inc. provides ophthalmic services. It engages in the provision of ophthalmic services and it specializes in allergy, allergic rhinitis, dry-eye, retina, anti-infective, anti-inflammatory, glaucoma, drug delivery, and ophthalmic devices. The firm offers development services including preclinical models, clinical research and development, regulatory strategy, statistics and data management, medical writing, and marketing and advertising. The company was founded by Mark Barry Abelson in 1985 and is headquartered in Andover, MA. | Medical/Nursing Services | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin | |
| University of California, Berkeley | College/University | Masters Business Admin Undergraduate Degree | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| TETRAPHASE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TENAX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Bayon Therapeutics, Inc. | Founder Founder | ||
Okogen, Inc.
 Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA. | Miscellaneous Commercial Services | Founder Founder | |
Voisin Consulting, Inc.
 Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Voisin Consulting, Inc. provides product development consulting services. It guides biotechnology, pharmaceutical and medical technology manufacturers throughout product development and commercialization. The company was founded by Emanuelle M. Viosin in 1997 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Ecole Polytechnique | College/University | Undergraduate Degree | |
Emosis SAS
 Emosis SAS Miscellaneous Commercial ServicesCommercial Services Emosis SAS engages in research and experimental development on natural science and engineering. It addresses the unmet testing needs of patients presenting a broad range of conditions, such as cardiovascular and cerebrovascular diseases, cancer, pregnancy or surgical complications and complication of oral contraceptives, associated with bleeding and blood clotting disorders hemostasis and thrombosis in medical parlance. The company was founded by Aaron Tomer and Frederic Allemand in 2015 and is headquartered in Illikirch-Graffenstaden, France. | Miscellaneous Commercial Services | Director/Board Member | |
| Alliances Internationale | Corporate Officer/Principal | ||
| SENSORION | Pharmaceuticals: Major | Chairman | |
| GENOMIC VISION | Medical Specialties | Director/Board Member | |
| ViThera Pharmaceuticals, Inc. | Chief Executive Officer | ||
PALUMED SA
 PALUMED SA Pharmaceuticals: MajorHealth Technology PALUMED SA develops and produces pharmaceutical products for the treatment of Alzheimer's disease. The firm specializes in the development and production of new antimalarial agents and antibacterial molecules. The company was founded on December 8, 2000 and is headquartered in Castanet-Tolosan, France. | Pharmaceuticals: Major | Founder | |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Centre National de la Recherche Scientifique
 Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France. | General Government | Corporate Officer/Principal | |
MindSet Rx, Inc.
 MindSet Rx, Inc. Miscellaneous Commercial ServicesCommercial Services MindSet Rx, Inc. operates as a biotech company that offers solution for neurodegenerative diseases. The company was founded by Bernard Malfroy-Camine and Michel Baudry in 2008 and is headquartered in Arlington, MA. | Miscellaneous Commercial Services | Chief Executive Officer | |
Infocus Capital Partners
 Infocus Capital Partners Investment ManagersFinance InFocus Capital Partners (InFocus Capital Partners) is a venture capital firm founded in 2016 by Rob Rothman and Ron Weiss. The firm is headquartered in Jericho, New York. | Investment Managers | Consultant / Advisor | |
| ALKERMES PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Eukarion, Inc.
 Eukarion, Inc. Pharmaceuticals: MajorHealth Technology Eukarion, Inc. engages in the provision of medical research. It develops small molecule drugs for the treatment of degenerative and age-related disorders. The company was founded on January 25, 1991 and is headquartered in Arlington, MA. | Pharmaceuticals: Major | President | |
| Bates College | College/University | Undergraduate Degree | |
Osmotica Pharmaceutical Corp.
 Osmotica Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Osmotica Pharmaceutical Corp. provides drug delivery technologies and neurology based therapies. It develops and commercializes a portfolio of products related to central nervous system disorders with a focus in Parkinson's disease and related neurological disorders. The company was founded in 1986 and is headquartered in Bridgewater, GA. | Pharmaceuticals: Major | Director of Finance/CFO | |
| AERIE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
OccuRx Pty Ltd
 OccuRx Pty Ltd BiotechnologyHealth Technology OccuRx Pty Ltd provides biopharmaceutical services. It engages in the development of therapeutic strategies for the treatment of ophthalmic disorders associated with retinal fibrosis and inflammation. The company was founded by Darren J. Kelly in 2014 and is headquartered in Melbourne, Australia. | Biotechnology | Chief Executive Officer | |
| David Geffen School of Medicine | College/University | Doctorate Degree | |
| University of California, Los Angeles | College/University | Doctorate Degree | |
Yellowbrick Bio LLC
 Yellowbrick Bio LLC Pharmaceuticals: MajorHealth Technology Part of Kiora Pharmaceuticals, Inc., Yellowbrick Bio LLC is a company that manufactures ophthalmological pharmaceutical products. The company is based in Solana Beach, CA. The company was founded in 2020 by Brian Matthew Strem. Yellowbrick Bio was acquired by Kiora Pharmaceuticals, Inc. on October 21, 2021 for $7.22 million. | Pharmaceuticals: Major | Founder | |
Arnold & Mabel Beckman Foundation
 Arnold & Mabel Beckman Foundation Investment Trusts/Mutual FundsMiscellaneous Arnold & Mabel Beckman Foundation engages in the provision of support to young researchers. It focuses in the fields of chemistry and life sciences, broadly interpreted, and particularly to foster the invention of methods, instruments, and materials that open up new avenues of research and application in these sciences and related disciplines. It offers national programs and local community works. The company was founded by Arnold O. Beckman and Mabel Beckman in September 1977 and is headquartered in Irvine, CA. | Investment Trusts/Mutual Funds | Director/Board Member | |
| REVANCE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of Pennsylvania Medical Center | College/University | Doctorate Degree | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Stanford University | College/University | Undergraduate Degree | |
| NUMEREX CORP. | Computer Communications | Chief Executive Officer | |
| Max Planck Institute of Biochemistry | College/University | Doctorate Degree | |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| RESEARCH SOLUTIONS, INC. | Miscellaneous Commercial Services | Director/Board Member | |
| AVID TECHNOLOGY, INC. | Packaged Software | Director of Finance/CFO | |
| Boston College | College/University | Undergraduate Degree | |
| University of Illinois College of Medicine | College/University | Corporate Officer/Principal | |
| NUANCE COMMUNICATIONS, INC. | Packaged Software | Treasurer | |
| The Johns Hopkins University School of Medicine | College/University | Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 38 |
| France | 9 |
| Australie | 3 |
| Irlande | 2 |
| Allemagne | 2 |
Sectorielle
| Health Technology | 19 |
| Consumer Services | 15 |
| Commercial Services | 7 |
| Finance | 3 |
| Technology Services | 3 |
Opérationnelle
| Director/Board Member | 36 |
| Corporate Officer/Principal | 26 |
| Independent Dir/Board Member | 15 |
| Undergraduate Degree | 11 |
| Founder | 10 |
Relations les plus connectées
- Bourse
- Insiders
- Franz Obermayr
- Connexions Sociétés
